Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response

Blood

Volumn 102, Issue 4, 2003, Pages 1217-1223

  Seaton, Edward D ^b   Szydlo, Richard M ^b   Kanfer, Edward ^b   Apperley, Jane F ^b   Russell Jones, Robin ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

METHOXSALEN; UVADEX;

ADULT; ARTICLE; BLOOD CELL COUNT; CAUSE OF DEATH; CELL POPULATION; CLINICAL ARTICLE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LICHENOID; LIVER FUNCTION; LUNG FUNCTION; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; PUVA; REGRESSION ANALYSIS; SCLERODERMA; SCORING SYSTEM; SKIN; SKIN ULCER; STATISTICAL SIGNIFICANCE; STEM CELL TRANSPLANTATION; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0043240283     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-11-3351     Document Type: Article

References (37)

1. Ratanatharathorn V, Nash RA, Przepiorka D, et al. Phase III study comparing methotrexate and Tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation. Blood. 1998;92:2303-2314.
2. Nash RA, Antin JH, Karanes C, et al. Phase 3 study comparing methotrexate and tacrolimus with methotrexaie and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Blood. 2000;96:2062-2068.
3. Socie G, Stone JV, Wingard JR, et al. Long-term survival and late deaths after allogeneic bone marrow transplantation: Late Effects Working Committee of the International Bone Marrow Transplant Registry. New Engl J Med. 1999;341: 14-21.
4. Wingard JR, Piantadosi S, Vogelsang GB, et al. Predictors of death from chronic graft-versus-host disease after bone marrow transplantation. Blood. 1989;74:1428-1435.
5. Flowers MED, Kansu E, Sullivan KM. Pathophysiology and treatment of graft-versus-host disease. Hematol Oncol Clin N Am. 1999;13:1091-1112.
6. Gaziev D, Galimberti M, Lucarelli G, Polchi P. Chronic graft-versus-host disease: is there an alternative to the conventional treatment? Bone Marrow Transplant. 2000;25:689-696.
7. Deeg HJ. Modification of allointeractions after blood transfusion and marrow transplantation by ultraviolet light. Semin Hematol. 1992;29:95-101.
8. Ullrich SE. Photoactivation of T-cell function with psoralen and UVA radiation suppressed the induction of experimental murine graft-versus-host disease across major histocompatibility complex barriers. J Invest Dermatol. 1991;96:303-308.
9. Edelson R, Berger C, Basparro F, et al. Successful treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. New Engl J Med. 1987;316:297-303.
10. Evans AV, Wood BP, Scarisbrick JJ, et al. Extracorporeal photopheresis in Sezary syndrome: hematological parameters as predictors of response. Blood. 2001;98:1298-1301.
11. Barr ML, Meiser BM, Eisen HJ, et al. Photopheresis for the prevention of rejection in cardiac transplantation. N Engl J Med. 1998;339:1744-1751.
12. Constanzo-Nordin MR, Hubbell EA, O'Sullivan EJ, et al. Successful treatment of heart transplant rejection with photopheresis. Transplant. 1992; 53:808-815.
13. Owsianowski M, Gollnick H, Siegert W, Schwerdtfeger R, Orfanos CE. Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis. Bone Marrow Transplant. 1994;14:845-848.
14. Rossetti F, Dall'Amico R, Crovetti G, et al. Extracorporeal photochemotherapy for the treatment of graft-versus-host disease. Bone Marrow Transplant. 1996;18(suppl 2)175-181.
15. Dall'Amico R, Rossetti F, Zulian F, et al. Photopheresis in paediatric patients with drug-resistant chronic graft-versus-host disease. Br J Haematol. 1997;97:848-854.
16. Smith EP, Sniecinski I, Dagis AC, et al. Extracorporeal photochemotherapy for treatment of drug-resistant graft-vs.-host disease. Biol Blood Marrow Transplant. 1998;4:27-37.
17. Greinix HT, Volc-Platzer B, Rabitsch W, et al. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Blood. 1998; 92:3098-3104.
18. Dippel E, Goerdt S, Orfanos CE. Long-term extracorporeal photoimmunotherapy for treatment of chronic cutaneous graft-versus host disease: observations in four patients. Dermatology. 1999; 198:370-374.
19. Child FJ, Ratnavel R, Watkins P, et al. Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD). Bone Marrow Transplant. 1999;23:881-887.
20. Salvaneschi L, Perotti C, Zecca M, et al. Extracorporeal photochemotherapy for treatment of acute and chronic GVHD in childhood. Transfusion. 2001;41:1299-1305.
21. Besnier DP, Chabannes D, Mahe B, et al. Treatment of graft-versus-host disease by extracorporeal photochemotherapy: a pilot study. Transplantation. 1997;64:49-54.
22. Rossetti F, Zulian F, Dall'Amico R, Messina C, Montini G, Zacchello F. Extracorporeal photochemotherapy as single therapy for extensive, cutaneous, chronic graft-versus-host disease. Transplantation. 1995;59:149-151.
23. Konstantinow A, Balda B-R, Starz H, Gnekow A, Heidemann P. Chronic graft-versus-host disease: successful treatment with extracorporeal photochemotherapy: a follow up [letter]. Br J Dermatol. 1996;135:1007-1008.
24. Alcindor T, Gorgun G, Miller BK. Immunomodulatory effects of extracorporeal photochemotherapy in patients with extensive chronic graft-versus-host disease. Blood. 2001;98:1622-1625.
25. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man: a long term clinicopathological study of 20 Seattle patients. Am J Med. 1980;69:204-217.
26. Akpek G, Zahurak ML, Piantadosi S, et al. Development of a prognostic model for grading chronic graft-versus host disease. Blood. 2001;97:1219-1226.
27. Kaheleh MB, Sultany GL, Smith EA, Huffstutter JE, Loadhold CB, LeRoy EC. A modified scleroderma skin scoring method. Clin Exp Rheumatol. 1986;4:367-369.
28. McDonald GB, Shukman HM, Sullivan KM, Spencer GD. Intestinal and hepatic complications of human bone marrow transplantation: part II. Gastroenterology. 1986;90:770-784.
29. Curtis DJ, Smale A, Thien F, Schwarer AP, Szer J. Chronic airflow obstruction in long-term survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant. 1995;16:169-173.
30. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342:1334-1349.
31. Bladon J, Taylor PC. Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T-cell lymphoma and graft-versus-host disease patients. Br J Haematol. 1999;107:707-711.
32. Aringer M, Graininger WB, Smolen JS, et al. Photopheresis treatment enhances CD95 (Fas) expression in circulating lymphocytes of patients with systemic sclerosis and induces apoptosis. Br J Rheumatol. 1997;36:1276-1282.
33. Fadock VA, Bratton D, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit pro-inflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE-2 and PAF. J Clin Invest. 1998;101:890-898.
34. Voll R, Herrman E, Roth E, Stach C, Kalden JR, Girkontaite I. Immunosuppressive effects of apoptotic cells [letter]. Nature. 1997;390:350-351.
35. Shlomchik WD, Couzens MS, Tang CB, et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science. 1999;285:412-415.
36. Klingemann HG. Relevance and potential of natural killer cells in stem cell transplantation. Biol Blood Marrow Transplant. 2000;9:90-99.
37. Asai O, Longo D, Tian Z, et al. Suppression of graft-versus-host disease and amplification of graft-versus-tumour effects by activated natural killer cells after allogenic bone marrow transplantation. J Clin Invest. 1998;101:1835-1842.